Business Wire

Invacare Take Powerchairs to a New Level

Jaa

Global brand leader Invacare is once again raising the bar in the powerchair market, following on from the successful launch of the LiNX control system last year. Invacare has taken the smart technology a step further with a new touch screen remote, in-built Bluetooth technology, enhanced programming features and a range of specialist controls, all available on the remarkable Invacare LiNX powerchair range.

This Smart News Release features multimedia. View the full release here: http://www.businesswire.com/news/home/20170831005621/en/

Invacare TDX SP2 with LiNX (Photo: Business Wire)

Invacare TDX SP2 with LiNX (Photo: Business Wire)

Touch screen remote

Following extensive trials and consumer-led insights, Invacare can now bring touch screen technology, which is used daily on devices such as smartphones and tablets, to powerchairs. The innovative REM400 remote has an impressive 3.5” colour touch screen that puts the user in complete control. Its features include:

  • Swipe or tap operation
  • Direct or menu navigation access to profiles and functions
  • Adjustable brightness
  • Glove mode setting
  • Screen lock out function
  • Configured for left or right handed use

And it doesn’t end there. The REM400 has built-in Bluetooth which allows connection to PC’s, laptops and Macs. Its integrated mouse mover with on screen mouse clicks lets users connect to their world through their remote.

One of the great benefits of a touch screen remote is that there are no fixed buttons. This makes the REM400 suitable for those with more complex physical and cognitive needs.

Enhanced programming features

LiNX allows professionals to diagnose and update powerchairs more intuitively through its clean and simple interface. Changes can be made to a powerchair via a laptop, PC or iOS device which are connected to the powerchair through a wireless LiNX Access Key.

What makes LiNX programming so innovative is its ‘live’ feature. Changes can be made to the forward, reverse and turn speeds whilst the powerchair is being driven by the user. This increases the driving efficiency and experience and makes set-ups and adjustments easier and quicker for professionals. Feedback is immediate and it ensures the powerchair is configured specifically to the user.

The LiNX system also allows professionals to mix and match the drive, seating and environmental controls in-order-to customise the display to suit the user’s lifestyle. E.g. The profiles can be customised by names such as Home, Outdoor and Work, with functions specific to each one. Profiles can also be set by user input options i.e. head control.

Specialist controls

To maximise a user’s control and independence, the REM400 allows a selection of specialist user inputs to be used on Invacare’s remarkable powerchairs. They range from head controls, chin controls, Sip ‘n’ puff systems, joystick options, proximity switches and dual controls, allowing Invacare to provide a control solution for many powerchair users. To help professionals select the best control for a powerchair user,

Invacare has put together a useful app with five simple steps to assist with the process. Take a look at the app by visiting www.linx4you.com, plus it can be downloaded from the Google Play Store and Apple App Store.

The above offering is available on all Invacare LiNX powerchairs, with a selection of the specialist controls only compatible with the TDX SP2 Ultra Low Maxx - and it is with this chair that Invacare is now able to fully enter the complex rehab market.

TDX SP2 base update

The renowned base with its minimalist black bodywork has been further enhanced with an optional single sided fork. With no protruding screws or fork parts, it not only makes the chair look more appealing but also minimises the front width of the base.

What further complements the TDX SP2 is its new black non-marking tyres and castors along with its black rim, giving this already exceptional chair a more sophisticated appearance.

And finally, the TDX SP2 wouldn’t be a perfect fit for a user’s lifestyle if it didn’t come with a range of individual colour finishes. Shrouds come in a choice of ten colours that are both neutral and vibrant, with 10 attractive rim inserts also available. That’s 100 colour combinations in total!

Announcing the LiNX enhancement, Ilona Wiemann, Global Product Development Manager for Powered Mobility at Invacare International said: “Invacare is once again revolutionising power mobility and setting a new benchmark in this market segment. When first launched last year, LiNX promised to be the start of something different and special and it didn’t disappoint and now we are back with even more innovations and smart technology.”

To find out more about Invacare LiNX, please visit www.invacarelinx.com.

To find out more about the TDX SP2 with Ultra Low Maxx and LiNX, please visit www.invacareULM.com.

About Invacare

Invacare Corporation (NYSE:IVC), headquartered in Elyria, Ohio, is the global leader in the manufacture and distribution of innovative home and long-term care medical products that promote recovery and active lifestyles. The Company currently has 5,400 associates and markets its products in approximately 80 countries around the world.

Contact information

Invacare
Samantha Hatchett
EMEA Marketing Communications Executive
01656 776236
or
EMEA Communication Team
Invacare International Sàrl
emeacomms@invacare.com
www.invacare.eu.com

Tietoja julkaisijasta

For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.

Tilaa tiedotteet sähköpostiisi

Haluatko tietää asioista jo ennen kuin ne uutisoidaan? Kun tilaat tiedotteemme, saat ne sähköpostiisi yhtä aikaa suomalaisen median kanssa. Tilauksen voit halutessasi perua milloin tahansa.

Lue lisää julkaisijalta Business Wire

First Westinghouse AP1000® Nuclear Plant Sanmen 1 Completes Initial Criticality21.6.2018 23:24Tiedote

Westinghouse Electric Company, China State Nuclear Power Technology Corporation (SNPTC) announced today that the world’s first AP1000 nuclear power plant located in Sanmen, Zhejiang Province, China has successfully completed initial criticality. “Today we completed the final major milestone before commercial operation for Westinghouse’s AP1000 nuclear power plant technology,” said José Emeterio Gutiérrez, Westinghouse president and chief executive officer. “We are one step closer to delivering the world’s first AP1000 plant to our customer and the world – with our customers, we will provide our customers in China with safe, reliable and clean energy from Sanmen 1.” Following initial criticality will be connection to the electrical grid. Once plant operations begin at Sanmen 1, it will be the first AP1000 nuclear power plant in operation, offering innovative passive safety system technology, multiple layers of defense and advanced controls for unequaled reliability and safety. Commentin

Westinghouse Loads Fuel in Second AP1000® Nuclear Power Plant21.6.2018 23:07Tiedote

Westinghouse Electric Company and its customers, China State Nuclear Power Technology Corporation (SNPTC) and Shangdong Nuclear Power Company Limited (SDNPC) announced today that Haiyang Unit 1, the AP1000 nuclear power plant located in Haiyang, Shandong Province, China, has begun to load fuel. “This is a great day for Westinghouse, our China partners and the nuclear industry. Haiyang Unit 1 continues to demonstrate our ability to deliver safe, innovative solutions for power generation,” said José Emeterio Gutiérrez, Westinghouse president and chief executive officer. He added, “Westinghouse will continue to deploy AP1000 technology throughout the world and demonstrate our technical leadership in the nuclear energy industry.” Fuel load at Haiyang Unit 1 commenced at 7:36 p.m. (GMT+8) today. Earlier this summer, in preparation for fuel load, Haiyang Unit 1 successfully completed the necessary testing and regulatory reviews conducted by China’s National Nuclear Safety Administration (NNS

Pharnext to Announce Top-Line Results from the Pivotal Phase 3 Trial of PXT3003 for the Treatment of Charcot-Marie-Tooth Type 1A Disease by October 201821.6.2018 21:23Tiedote

Regulatory News: Pharnext SA (Paris:ALPHA) (FR0011191287 - ALPHA), a biopharmaceutical company pioneering a new approach to the development of innovative drug combinations based on big data genomics and artificial intelligence, today announced an update from its ongoing Phase 3 clinical program (PLEO-CMT and PLEO-CMT-FU studies) evaluating PXT3003 for the treatment of Charcot-Marie-Tooth type 1A disease (CMT1A) in adults. Top-line results from the pivotal PLEO-CMT study are now expected by October 2018. Prof. Daniel Cohen, M.D., Ph.D., Pharnext’s Co-Founder and Chief Executive Officer said: “We are thrilled to bring this Phase 3 clinical trial to completion and we now expect to disclose top-line results by October of this year. Our PLEODRUG™ PXT3003 has already shown initial signals of efficacy in our Phase 2 trial in CMT1A. We are hopeful we can bring this much-needed therapy to patients suffering from this debilitating condition, as they currently have limited therapeutic options, mo

Philip Morris International Makes Call to Creative, Media and Communications Communities21.6.2018 21:13Tiedote

Philip Morris International Inc. (“PMI”) (NYSE: PM), today announced a bold call to action for the creative, media and communications communities to embrace its ongoing commitment to creating a smoke-free world. As part of this initiative, PMI will offer smoke-free alternatives wherever we can, including heated tobacco products and e-cigarettes, to current smokers in the industry who would otherwise continue to smoke. During a keynote at the PMI Science Lounge at The Cannes Festival of Creativity, SVP of Communications Marian Salzman said, “We are asking the creative community to join us in raising awareness of the potential of science, technology and innovation for those who smoke and the people around them.” The move is part of PMI’s vision to lead the charge towards greater innovation and technology in the tobacco industry, all of which is backed by science. Agencies interested in joining the movement can contact Marian Salzman at marian.salzman@pmi.com. “People who smoke deserve in

IBC2018 Announces Cyber Security Forum to Help Media Tackle Cyber Threats21.6.2018 19:30Tiedote

IBC2018, the world’s most influential media, entertainment and technology show, today announces a Cyber Security Forum to expand its position as the preeminent cyber security destination for broadcasters and media. The event will form part of the prestigious annual IBC show at the RAI in Amsterdam from Thursday 13 to Tuesday 18 September 2018, which last year attracted more than 57,000 attendees from 170 countries. The Cyber Security Forum is one-day, invitation-only event that will convene Chief Technology Officers, Chief Information Officers, Chief Information Security Officers and Chief Digital Officers within media and broadcasting for a conversation on the challenges and opportunities presented by cyber security for broadcasters. Attendees will discuss how to anticipate the next cyber threat, how to manage a breach and how to prepare for the future of cyber security. The Cyber Security Forum sits alongside the Telco & Media Innovation Forum and Leaders’ Forum as part of IBC’s Exec

Mensia Technologies Raises 1,3 Million Euro to Introduce Koala Neurofeedback as a Revolutionary Medical Device in Europe21.6.2018 19:23Tiedote

Mensia Technologies, french MedTech start up, leads the new booming category of Digital therapeutics with its revolutionary « at home « neurofeedback, to train the brain and cure neuropsy disorders without drugs. Co-founder INRIA-IT2, existing shareholders and now HARA, which are business angels experts in medical device category, joined this fund raise. BPI de Rennes is also part of this tour. Mensia Technologies, borned out of INRIA in 2012. The IT expert labs in Rennes are computing real time signaling softwares. The neurofeedback technique is non invasive, at home and without drugs. MENSIA KOALA treats ADHD, Attention Deficit Disorders with or without Hyperactivity, children and adolescents. This unique medical device is a therapeutic video game on an interactive tablet connected to the brain activity. Children learn to control their attention by exercising 3 times a week during 4 months of treatment. Visual feedback given during the game, allows the children to learn, control and

Uutishuoneessa voit lukea tiedotteitamme ja muuta julkaisemaamme materiaalia. Löydät sieltä niin yhteyshenkilöidemme tiedot kuin vapaasti julkaistavissa olevia kuvia ja videoita. Uutishuoneessa voit nähdä myös sosiaalisen median sisältöjä. Kaikki STT Infossa julkaistu materiaali on vapaasti median käytettävissä.

Tutustu uutishuoneeseemme